Osteopore Ltd
Osteopore Expands Orthopaedic Business into Hong Kong with MontsMed Distribution Agreement
Osteopore (ASX: OSX) is set to expand its orthopaedic business into Hong Kong after signing a new distribution agreement with local company MontsMed, marking the next step in the company’s planned commercial expansion across the Asia Pacific region.
Osteopore Granted Swiss Market Approval for Custom Bioresorbable Implants
Regenerative medicine company Osteopore (ASX: OSX) has secured market approval in Switzerland for its off-the-shelf and custom-made biomimetic and bioresorbable implants. Approval came under the European Union’s medical device regulations (MDR) and follows the company’s partnership with US orthopaedic solutions company Zimmer Biomet to distribute its craniofacial products in Europe, the Middle East and Africa, the […]
Osteopore granted European market approval for custom orthopaedic and cranial implants
Regenerative medicine company Osteopore (ASX: OSX) has secured European Union medical device regulation approval for its custom orthopaedic and cranial implants. The approval unlocks opportunities for the company to offer high-value custom implants to the European market to complement its range of off-the-shelf neurosurgical and craniofacial implants. Osteopore will distribute the products via an exclusive […]
Osteopore granted regulatory approval for innovative bone reconstruction procedures in Singapore and Vietnam
Regenerative medicine specialist Osteopore (ASX: OSX) is set to help relieve the knee pain of thousands of sufferers with the company now able to use several of its procedures in Singapore and Vietnam. In a milestone for Osteopore’s growth strategy, the company’s aXOpore technology has been granted regulatory clearance by Singapore’s Health Sciences Authority and […]